Annual Accounts Receivable
$8.22 B
+$106.00 M+1.31%
31 December 2023
Summary:
Thermo Fisher Scientific annual accounts receivable is currently $8.22 billion, with the most recent change of +$106.00 million (+1.31%) on 31 December 2023. During the last 3 years, it has risen by +$2.48 billion (+43.20%). TMO annual accounts receivable is now at all-time high.TMO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$8.26 B
+$312.00 M+3.93%
28 September 2024
Summary:
Thermo Fisher Scientific quarterly accounts receivable is currently $8.26 billion, with the most recent change of +$312.00 million (+3.93%) on 28 September 2024. Over the past year, it has dropped by -$115.00 million (-1.37%). TMO quarterly accounts receivable is now -1.37% below its all-time high of $8.37 billion, reached on 30 September 2023.TMO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TMO Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.3% | -1.4% |
| 3 y3 years | +43.2% | +48.5% |
| 5 y5 years | +98.8% | +88.3% |
TMO Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +43.2% | -1.4% | +48.5% |
| 5 y | 5 years | at high | +98.8% | -1.4% | +89.8% |
| alltime | all time | at high | +1900.4% | -1.4% | +1976.2% |
Thermo Fisher Scientific Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.26 B(+3.9%) |
| June 2024 | - | $7.94 B(+0.2%) |
| Mar 2024 | - | $7.93 B(-3.5%) |
| Dec 2023 | $8.22 B(+1.3%) | $8.22 B(-1.8%) |
| Sept 2023 | - | $8.37 B(+4.4%) |
| June 2023 | - | $8.02 B(+1.2%) |
| Mar 2023 | - | $7.92 B(-2.4%) |
| Dec 2022 | $8.12 B(+1.7%) | $8.12 B(+5.8%) |
| Sept 2022 | - | $7.67 B(-1.0%) |
| June 2022 | - | $7.75 B(-1.8%) |
| Mar 2022 | - | $7.89 B(-1.1%) |
| Dec 2021 | $7.98 B(+38.9%) | $7.98 B(+43.5%) |
| Sept 2021 | - | $5.56 B(+1.5%) |
| June 2021 | - | $5.48 B(-1.4%) |
| Mar 2021 | - | $5.55 B(-3.3%) |
| Dec 2020 | $5.74 B(+32.0%) | $5.74 B(+10.7%) |
| Sept 2020 | - | $5.19 B(+15.8%) |
| June 2020 | - | $4.48 B(-0.7%) |
| Mar 2020 | - | $4.51 B(+3.7%) |
| Dec 2019 | $4.35 B(+5.1%) | $4.35 B(-0.8%) |
| Sept 2019 | - | $4.38 B(+6.2%) |
| June 2019 | - | $4.13 B(-0.6%) |
| Mar 2019 | - | $4.16 B(+0.5%) |
| Dec 2018 | $4.14 B(+6.6%) | $4.14 B(+7.4%) |
| Sept 2018 | - | $3.85 B(-1.5%) |
| June 2018 | - | $3.91 B(-2.0%) |
| Mar 2018 | - | $3.99 B(+2.9%) |
| Dec 2017 | $3.88 B(+27.2%) | $3.88 B(+6.1%) |
| Sept 2017 | - | $3.66 B(+12.2%) |
| June 2017 | - | $3.26 B(+5.2%) |
| Mar 2017 | - | $3.10 B(+1.6%) |
| Dec 2016 | $3.05 B(+19.8%) | $3.05 B(+5.3%) |
| Sept 2016 | - | $2.90 B(+6.9%) |
| June 2016 | - | $2.71 B(+1.5%) |
| Mar 2016 | - | $2.67 B(+4.8%) |
| Dec 2015 | $2.54 B(+2.9%) | $2.54 B(+0.0%) |
| Sept 2015 | - | $2.54 B(-3.3%) |
| June 2015 | - | $2.63 B(+3.7%) |
| Mar 2015 | - | $2.54 B(+2.6%) |
| Dec 2014 | $2.47 B(+27.4%) | $2.47 B(-1.3%) |
| Sept 2014 | - | $2.51 B(-5.8%) |
| June 2014 | - | $2.66 B(-1.3%) |
| Mar 2014 | - | $2.70 B(+38.8%) |
| Dec 2013 | $1.94 B(+7.6%) | $1.94 B(-0.1%) |
| Sept 2013 | - | $1.95 B(+2.3%) |
| June 2013 | - | $1.90 B(-0.2%) |
| Mar 2013 | - | $1.90 B(+5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $1.80 B(+2.3%) | $1.80 B(-1.3%) |
| Sept 2012 | - | $1.83 B(+1.4%) |
| June 2012 | - | $1.80 B(-4.8%) |
| Mar 2012 | - | $1.89 B(+7.4%) |
| Dec 2011 | $1.76 B(+19.7%) | $1.76 B(-2.6%) |
| Sept 2011 | - | $1.81 B(+7.6%) |
| June 2011 | - | $1.68 B(+7.5%) |
| Mar 2011 | - | $1.57 B(+6.2%) |
| Dec 2010 | $1.47 B(+4.6%) | $1.47 B(+0.1%) |
| June 2010 | - | $1.47 B(-1.4%) |
| Mar 2010 | - | $1.49 B(+6.0%) |
| Dec 2009 | $1.41 B(-4.6%) | $1.41 B(-4.9%) |
| Sept 2009 | - | $1.48 B(+0.8%) |
| June 2009 | - | $1.47 B(+3.3%) |
| Mar 2009 | - | $1.42 B(-3.7%) |
| Dec 2008 | $1.48 B(+1.9%) | $1.48 B(-4.2%) |
| Sept 2008 | - | $1.54 B(-3.5%) |
| June 2008 | - | $1.60 B(+0.8%) |
| Mar 2008 | - | $1.59 B(+9.4%) |
| Dec 2007 | $1.45 B(+4.1%) | $1.45 B(-0.6%) |
| Sept 2007 | - | $1.46 B(+2.5%) |
| June 2007 | - | $1.42 B(+0.2%) |
| Mar 2007 | - | $1.42 B(+1.9%) |
| Dec 2006 | $1.39 B(+148.6%) | $1.39 B(+158.0%) |
| Sept 2006 | - | $539.84 M(-0.9%) |
| June 2006 | - | $544.52 M(+0.3%) |
| Mar 2006 | - | $542.93 M(-3.1%) |
| Dec 2005 | $560.17 M(+19.3%) | $560.17 M(+7.4%) |
| Sept 2005 | - | $521.38 M(+1.7%) |
| June 2005 | - | $512.65 M(+11.8%) |
| Mar 2005 | - | $458.56 M(-2.3%) |
| Dec 2004 | $469.55 M(+11.9%) | $469.55 M(+9.4%) |
| Sept 2004 | - | $429.39 M(+3.6%) |
| June 2004 | - | $414.37 M(-9.6%) |
| Mar 2004 | - | $458.13 M(+9.2%) |
| Dec 2003 | $419.63 M(-2.4%) | $419.63 M(-1.0%) |
| Sept 2003 | - | $423.94 M(+4.5%) |
| June 2003 | - | $405.60 M(-1.7%) |
| Mar 2003 | - | $412.41 M(-4.0%) |
| Dec 2002 | $429.74 M(+4.6%) | $429.74 M(+3.9%) |
| Sept 2002 | - | $413.73 M(+0.6%) |
| June 2002 | - | $411.15 M(+3.4%) |
| Mar 2002 | - | $397.61 M(-3.2%) |
| Dec 2001 | $410.96 M(-8.7%) | $410.96 M(-0.3%) |
| Sept 2001 | - | $412.35 M(+1.7%) |
| June 2001 | - | $405.53 M(-5.4%) |
| Mar 2001 | - | $428.46 M(-4.8%) |
| Dec 2000 | $450.00 M | $450.00 M |
FAQ
- What is Thermo Fisher Scientific annual accounts receivable?
- What is the all time high annual accounts receivable for Thermo Fisher Scientific?
- What is Thermo Fisher Scientific annual accounts receivable year-on-year change?
- What is Thermo Fisher Scientific quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Thermo Fisher Scientific?
- What is Thermo Fisher Scientific quarterly accounts receivable year-on-year change?
What is Thermo Fisher Scientific annual accounts receivable?
The current annual accounts receivable of TMO is $8.22 B
What is the all time high annual accounts receivable for Thermo Fisher Scientific?
Thermo Fisher Scientific all-time high annual accounts receivable is $8.22 B
What is Thermo Fisher Scientific annual accounts receivable year-on-year change?
Over the past year, TMO annual accounts receivable has changed by +$106.00 M (+1.31%)
What is Thermo Fisher Scientific quarterly accounts receivable?
The current quarterly accounts receivable of TMO is $8.26 B
What is the all time high quarterly accounts receivable for Thermo Fisher Scientific?
Thermo Fisher Scientific all-time high quarterly accounts receivable is $8.37 B
What is Thermo Fisher Scientific quarterly accounts receivable year-on-year change?
Over the past year, TMO quarterly accounts receivable has changed by -$115.00 M (-1.37%)